Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Loan Conversion

23 Dec 2005 07:00

Embargoed Release: 07:00hrs Friday 23rd December 2005 SOPHEON PLC Conversion of loan stock Extension of Equity Line Agreement International Financial Reporting Standards Change of Auditors Sopheon plc announces that it has issued 10,197,327 ordinary shares inconnection with the maturity of its remaining balance of ‚£1,223,679 ofconvertible loan stock. The convertible loan stock is now fully converted, asforeseen in Sopheon's annual report and other announcements. The conversion hasresulted in the issue of 3,250,000 ordinary shares to Mr B K Mence, a director,changing the total holding in which Mr Mence is beneficially interested to14,423,847 ordinary shares, representing 10.8% of the Company's issued sharecapital. The conversion has also resulted in the issue of 5,416,667 ordinaryshares to Norman Nominees Limited, changing its total shareholding to 9,891,260ordinary shares, representing 7.4% of the Company's issued share capital.Application has been made for the new ordinary shares, which are subject tocertain lock-in requirements, to be admitted to trading on AIM. Dealings areexpected to commence on 3 January 2006.Sopheon is also pleased to advise that its equity line of credit facility withGEM Global Yield Fund Limited ("GEM") due to expire today has been extended fora two year period through to 23 December 2007. As part of the agreement, thecosts of the extension, as well as outstanding commitment fees relating to theinitial term, have been satisfied by the issue of 400,000 ordinary shares toGEM at a price of 18p per ordinary share. Over 90% of the original ¢â€š¬10mfacility remains available under the extended agreeement. Application has beenmade for the new ordinary shares to be admitted to trading on AIM, and dealingsare expected to commence on 3 January 2006.Although Sopheon's AIM listing provides for an exemption from the adoption ofInternational Financial Reporting Standards ("IFRS") until the financialstatements for the year 2007, the board has continued to evaluate the relativemerits of early adoption of IFRS as opposed to continued application of UKGAAP. In view of the increasing importance of the group's shareholders thattrade through Euronext, coupled with the effect of extensive changes comingthrough in UK GAAP relating to its convergence with IFRS, the board has nowconcluded in consultation with its advisers that adoption of IFRS as of the2005 financial statements is appropriate.A detailed evaluation of the effects of the adoption of IFRS on Sopheon'sfinancial statements is ongoing but the preliminary conclusions as to the keyareas likely to be materially affected are (i) an option pricing model will beused to work out the fair value of share options granted during a period, withthis value being charged to the profit and loss account over the expectedvesting period; (ii) certain research and development expenditure may becapitalised and amortised based on detailed technical criteria, rather thanautomatically charging such costs in the profit and loss account as they arise;(iii) certain short term non-trade payables and receivables may requirerestatement or reclassification and (iv) certain acquired goodwill may requirereclassification as an intangible asset. It is not expected that the treatmentand reporting of Sopheon's revenues will be affected by the adoption of IFRS.Finally, the Sopheon board wishes to announce that BDO Stoy Hayward hasreplaced Ernst & Young as auditors with immediate effect. BDO is the world'sfifth largest accountancy network. Its focus on growth oriented companiesaligns well with Sopheon's business characteristics, and will deliver a morecost effective audit service. The BDO member firms in the Netherlands and inthe USA are respectively BDO CampsObers Accountants & Belastingadviseurs, andBDO Seidman LLP. Ernst & Young remain Sopheon's tax advisers.For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 ENDSOPHEON PLC
Date   Source Headline
10th Jun 20217:00 amRNSAGM Statement
3rd Jun 20211:50 pmRNSIssue of Equity
2nd Jun 20217:00 amRNSSopheon Deployed Globally at The 3M Company
14th May 202110:11 amRNSGrant of Options / PDMR dealing
14th Apr 20217:00 amRNSLaunch of Accolade for Smart Products
9th Apr 20214:15 pmRNSIssue of Equity
31st Mar 20217:00 amRNSDirectorate Change
29th Mar 20212:30 pmRNSDirector Shareholdings
24th Mar 20217:00 amRNSFinal Results
3rd Mar 202111:02 amRNSHolding(s) in Company
2nd Mar 202112:12 pmRNSHolding(s) in Company
26th Feb 20214:20 pmRNSResult of Secondary Placing
26th Feb 20211:36 pmRNSProposed Secondary Placing
8th Feb 20214:30 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSSopheon extend innovation leadership with Simplot
25th Jan 20217:00 amRNSTrading Update
5th Nov 20207:00 amRNSRelease of Accolade version 13.2
12th Oct 20207:00 amRNSSeasoned Cloud & Industry Executive added to Team
9th Sep 20209:55 amRNSOrion Engineered Carbons works with Sopheon
1st Sep 202011:38 amRNSDirector Shareholdings
28th Aug 202012:39 pmRNSIssue of Equity
27th Aug 20207:00 amRNSInterim Results
30th Jul 20207:00 amRNSMondelez Partnership
13th Jul 202011:41 amRNSGrant of Options/PDMR Dealing
11th Jun 202011:28 amRNSResult of AGM
9th Jun 202012:00 pmRNSIssue of Equity & Director/PDMR Shareholding
28th May 20207:29 amRNSProgressive publishes new research
28th May 20207:00 amRNSNew Sopheon Release Integrating Microsoft Teams
15th May 202010:01 amRNSIssue of Equity
15th May 20207:00 amRNSAGM Notice and Update
3rd Apr 202011:17 amRNSDirector Shareholdings
25th Mar 20201:38 pmRNSIssue of Equity
19th Mar 20204:46 pmRNSIssue of Equity
19th Mar 20207:00 amRNSFinal Results
28th Jan 20209:05 amRNSSecond Price Monitoring Extn
28th Jan 20209:00 amRNSPrice Monitoring Extension
28th Jan 20207:00 amRNSTrading Update
10th Jan 20201:00 pmRNSIssue of Equity
11th Dec 20197:00 amRNSTrading Update
10th Oct 201912:00 pmRNSIssue of Equity
1st Oct 201912:00 pmRNSIssue of Equity
20th Sep 20194:45 pmRNSIssue of Equity
22nd Aug 20192:06 pmRNSSecond Price Monitoring Extn
22nd Aug 20192:01 pmRNSPrice Monitoring Extension
22nd Aug 201911:05 amRNSSecond Price Monitoring Extn
22nd Aug 201911:00 amRNSPrice Monitoring Extension
22nd Aug 20199:05 amRNSSecond Price Monitoring Extn
22nd Aug 20199:00 amRNSPrice Monitoring Extension
22nd Aug 20197:00 amRNSHalf-year Report
12th Aug 201910:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.